These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10834782)

  • 1. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.
    Atanassoff PG; Hartmannsgruber MW; Thrasher J; Wermeling D; Longton W; Gaeta R; Singh T; Mayo M; McGuire D; Luther RR
    Reg Anesth Pain Med; 2000; 25(3):274-8. PubMed ID: 10834782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
    Klotz U
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
    Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
    Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
    Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
    Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain.
    Wang YX; Pettus M; Gao D; Phillips C; Scott Bowersox S
    Pain; 2000 Feb; 84(2-3):151-8. PubMed ID: 10666519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
    Wermeling DP
    Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative nimodipine and postoperative analgesia.
    Casey G; Nortcliffe SA; Sharpe P; Buggy DJ
    Anesth Analg; 2006 Feb; 102(2):504-8. PubMed ID: 16428551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziconotide: can we use it in palliative care?
    Prommer EE
    Am J Hosp Palliat Care; 2005; 22(5):369-74. PubMed ID: 16225359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.
    Rauck RL; Wallace MS; Leong MS; Minehart M; Webster LR; Charapata SG; Abraham JE; Buffington DE; Ellis D; Kartzinel R;
    J Pain Symptom Manage; 2006 May; 31(5):393-406. PubMed ID: 16716870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziconotide: a clinical update and pharmacologic review.
    Pope JE; Deer TR
    Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal ziconotide for refractory chronic pain.
    Lynch SS; Cheng CM; Yee JL
    Ann Pharmacother; 2006; 40(7-8):1293-300. PubMed ID: 16849624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose intrathecal morphine effects on post-hysterectomy pain: a randomized placebo-controlled study.
    Hein A; Rösblad P; Gillis-Haegerstrand C; Schedvins K; Jakobsson J; Dahlgren G
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):102-9. PubMed ID: 22150410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent.
    Yan LD; Liu YL; Zhang L; Dong HJ; Zhou PL; Su RB; Gong ZH; Huang PT
    Eur J Pharmacol; 2010 Jun; 636(1-3):73-81. PubMed ID: 20361956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the dose of intrathecal morphine in older patients undergoing hip arthroplasty.
    Murphy PM; Stack D; Kinirons B; Laffey JG
    Anesth Analg; 2003 Dec; 97(6):1709-1715. PubMed ID: 14633547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
    Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
    Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects associated with the intrathecal administration of ziconotide.
    Penn RD; Paice JA
    Pain; 2000 Mar; 85(1-2):291-6. PubMed ID: 10692631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.